Compounds > voriconazole
Page last updated: 2024-08-25

voriconazole and Mucorales Infection

voriconazole has been researched along with Mucorales Infection in 57 studies

Research

Studies (57)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's21 (36.84)29.6817
2010's29 (50.88)24.3611
2020's7 (12.28)2.80

Authors

AuthorsStudies
Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA1
Calvo, E; Guarro, J; Pastor, FJ; Rodríguez, MM; Salas, V; Sutton, DA1
Guarro, J; Mayayo, E; Pastor, FJ; Pujol, I; Ruíz-Cendoya, M; Sutton, DA1
Buil, JB; den Dekker, BM; Festen, B; Heusinkveld, M; Melchers, M; Mooren, ERM; Schellaars, R; van Binsbergen, AL; van Bree, SHW; van Zanten, ARH; Verweij, PE1
Doki, N; Fukushima, K; Funata, N; Hishima, T; Horiguchi, SI; Igarashi, A; Inamoto, K; Kaito, S; Kakihana, K; Kishida, Y; Kobayashi, T; Konishi, T; Kurosawa, S; Nagata, A; Najima, Y; Ohashi, K; Sakamaki, H; Sekiya, N; Shimizu, H; Shingai, N; Shirane, S; Toya, T; Uchida, T; Yamada, Y; Yoshifuji, K1
Akashi, K; Izumikawa, K; Kakeya, H; Kamei, K; Kanda, Y; Kimura, SI; Kishida, M; Kohno, S; Matsuda, M; Miyazaki, T; Miyazaki, Y; Mukae, H; Niki, Y; Ogawa, K; Okada, F; Suzuki, J; Takazono, T; Taniguchi, S; Tateda, K; Yoshida, M1
Cho, SY; Jung, JI; Lee, DG; Lee, KY; Park, YJ; Yi, Y1
Choi, S; Choi, SH; Chong, YP; Jung, J; Kim, MJ; Kim, SH; Kim, YS; Lee, SO; Son, HJ; Song, JS; Woo, JH1
Azanza, JR; Grau, S; López-Gómez, V; López-Ibáñez de Aldecoa, A; Peral, C; Rebollo, P; Vázquez, L1
Mammen, MD; Rupa, V; Sahni, RD; Varghese, GM1
Bassetti, M; Bouza, E1
Denis, J; Herbrecht, R; Ledoux, MP; Toussaint, E1
Abdi, R; Aghili, SR; Ghasemian, R; Gholinejad-Ghadi, N; Seifi, Z; Sharifpour, A; Shokohi, T; Zaboli, E1
Cabeza, MS; Dudiuk, C; Gamarra, S; Garcia-Effron, G; Leonardelli, F; Macedo, D; Theill, L1
Bagshaw, E; Floros, L; Kuessner, D; Posthumus, J; Sjölin, J1
Dehghan Manshadi, SA; Giasvand, F; Jahanbin, B; Khodaveisi, S; Safai Nodeh, SR; Salehi, M; Seifi, A1
Azari, AA; Ghoghawala, SY; Kanavi, MR; Lee, V; Nehls, S; Potter, HD1
Leroux, S; Ullmann, AJ1
Abidi, MZ; Brumble, L; Cummins, N; Jane Hata, D; Kusne, S; Lahr, BD; Letendre, L; Litzow, M; McCullough, A; Poeschla, E; Shah, H; Sohail, MR; Vikram, HR; Walker, RC; Wendel, A; Wengenack, N; Wilhelm, M1
Alfaya Muñoz, L; Avendaño Cantos, EM; Celis Sánchez, J; Mesa Varona, D; Romero Moraleda, L1
Marr, K; Ostrander, D; Shoham, S1
Akers, KS; Chung, KK; Graybill, JC; Mende, K; Murray, CK; Niece, KL; Rowan, MP1
Albert, ND; Bellanger, AP; Kontoyiannis, DP; Lewis, RE; Walsh, TJ1
Chowdhary, A; Hagen, F; Kathuria, S; Meis, JF; Singh, PK1
Alkhazraji, S; Baldin, C; Gebremariam, T; Ibrahim, AS; Kovanda, L; Wiederhold, NP1
de Mol, P; Meis, JF1
Alp, S; Arikan, S; Hascelik, G; McNicholas, P; Sancak, B1
Kida, M1
Alastruey-Izquierdo, A; Castelli, MV; Cuesta, I; Mellado, E; Monzón, A; Rodríguez-Tudela, JL; Zaragoza, O1
Kontoyiannis, DP; Lewis, RE; Pongas, GN; Samonis, G1
Cornely, OA1
Bernardin, G; Burel-Vandenbos, F; Dunais, B; Gari-Toussaint, M; Guidicelli, S; Hyvernat, H1
Lagrou, K; Maertens, J; Meersseman, W; Saegeman, V; Spriet, I; Verbeken, E1
Bajwa, RP; Fung, B; Garee, A; Gross, TG; Pietryga, D; Rawlinson, NJ; Skeens, M; Soni, S; Termuhlen, AM1
Aiba, K; Dobashi, N; Kasama, K; Katsube, A; Machishima, T; Minami, J; Nishiwaki, K; Ogasawara, Y; Saito, T; Shimada, T; Sugiyama, K; Takahara, S; Takei, Y; Usui, N; Yahagi, Y; Yamaguchi, Y; Yano, S; Yokoyama, H1
Avery, S; Chang, CC; Grigoriadis, G; Morrissey, O; Patil, S; Spencer, A; Walker, P1
Agrawal, S; Bali, R; Bhagol, A; Sen, R; Sharma, B; Singh, V1
Arda, B; Ceylan, N; Erdem, A; Işıkgöz Taşbakan, M; Metin, DY; Midilli, R; Pullukçu, H; Sipahi, OR; Taşbakan, MS; Ulusoy, S; Yamazhan, T1
Kontoyiannis, DP; Lewis, RE; Lortholary, O; Roilides, E; Spellberg, B; Walsh, TJ1
Ibrahim, A; Kontoyiannis, DP; Lewis, RE; Lortholary, O; Lotholary, O; Petrikkos, G; Roilides, E; Roillides, E; Spellberg, B; Walsh, TJ1
Abu El-Naaj, I; Leiser, Y; Peled, M; Wolff, A1
Arabia, FA; Blair, JE; Kusne, S; Scott, RL; Steidley, DE; Vikram, HR; Webb, BJ1
Stevens, DA1
Miller, JL; Perfect, JR; Schell, WA; Steinbach, WJ1
Mattner, F; Strueber, M; Weissbrodt, H1
Blin, N; Gaillard, F; Harousseau, JL; Milpied, N; Moreau, P; Morin, O; Morineau, N1
Chevallier, P; Dubruille, V; Guillaume, T; Harousseau, JL; Mahé, B; Méchinaud, F; Milpied, N; Moreau, P; Morin, O; Morineau, N; Vigouroux, S1
Oren, I1
Bethge, WA; Einsele, H; Hebart, H; Horger, M; Kanz, L; Kröber, SM; Schmalzing, M; Schumacher, U; Stuhler, G1
Akova, M; Sahin, GO1
DeRemer, D; Fain, H; Farrow, S; Jillella, AP; Ustun, C1
Harada, AS; Lau, W1
Amedro, P; Blayac, JP; Cociglio, M; Eiden, C; Hillaire-Buys, D; Margueritte, G; Peyrière, H; Tichit, R1
Hosoki, T; Ikuta, K; Jimbo, J; Kohgo, Y; Nishimura, K; Sano, A; Sato, K; Shindo, M; Torimoto, Y1
Chacko, B; David, VG; Deepti, AN; John, GT; Tamilarasi, V1
Clauss, H; Samuel, R1
Baldelli, F; Costantini, V; Giovenale, P; Gurdo, G; Lapalorcia, LM; Lignani, A; Pasticci, MB; Pitzurra, L; Terenzi, A; Verzini, F1

Reviews

8 review(s) available for voriconazole and Mucorales Infection

ArticleYear
Central nervous system mucormycosis in a patient with hematological malignancy: A case report and review of the literature.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022, Volume: 28, Issue:12

    Topics: Adult; Amphotericin B; Antifungal Agents; Brain Abscess; Central Nervous System; Female; Hematologic Neoplasms; Humans; Mucormycosis; Voriconazole

2022
Invasive mould infections in the ICU setting: complexities and solutions.
    The Journal of antimicrobial chemotherapy, 2017, 03-01, Volume: 72, Issue:suppl_1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Critical Illness; Galactose; Humans; Immunocompromised Host; Intensive Care Units; Invasive Fungal Infections; Lung Diseases, Fungal; Mannans; Mucor; Mucormycosis; Nitriles; Opportunistic Infections; Pyridines; Respiratory System; Triazoles; Voriconazole

2017
Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: critical appraisal.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2013, Volume: 19, Issue:12

    Topics: Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Evidence-Based Medicine; Humans; Mucormycosis; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole

2013
In vitro activity of antifungals against Zygomycetes.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2009, Volume: 15 Suppl 5

    Topics: Amphotericin B; Antifungal Agents; Echinocandins; Humans; Microbial Sensitivity Tests; Mucorales; Mucormycosis; Pyrimidines; Triazoles; Voriconazole

2009
Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2009, Volume: 15 Suppl 5

    Topics: Antifungal Agents; Chemoprevention; Drug Resistance, Fungal; Humans; Immunocompromised Host; Mucorales; Mucormycosis; Pyrimidines; Transplantation; Triazoles; Voriconazole

2009
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide.
    Journal of clinical microbiology, 2003, Volume: 41, Issue:8

    Topics: Administration, Topical; Anti-Bacterial Agents; Antifungal Agents; Biguanides; Caspofungin; Child, Preschool; Disinfectants; Echinocandins; Humans; Lipopeptides; Magnetic Resonance Imaging; Male; Mucormycosis; Osteomyelitis; Peptides; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2003
Two case reports: fatal Absidia corymbifera pulmonary tract infection in the first postoperative phase of a lung transplant patient receiving voriconazole prophylaxis, and transient bronchial Absidia corymbifera colonization in a lung transplant patient.
    Scandinavian journal of infectious diseases, 2004, Volume: 36, Issue:4

    Topics: Absidia; Antibiotic Prophylaxis; Antifungal Agents; Bronchi; Fatal Outcome; Female; Humans; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Mucormycosis; Pyrimidines; Triazoles; Voriconazole

2004
Treatment of invasive infections due to rare or emerging yeasts and moulds.
    Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:9

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; Humans; Immunocompromised Host; Mucormycosis; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole

2006

Trials

1 trial(s) available for voriconazole and Mucorales Infection

ArticleYear
Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023, Volume: 29, Issue:2

    Topics: Antifungal Agents; Aspergillosis; Cryptococcosis; Humans; Invasive Fungal Infections; Japan; Mucormycosis; Pulmonary Aspergillosis; Triazoles; Voriconazole

2023

Other Studies

48 other study(ies) available for voriconazole and Mucorales Infection

ArticleYear
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2007
Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Kidney; Male; Mice; Mucormycosis; Rhizopus; Triazoles

2009
In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Amphotericin B; Animals; Antifungal Agents; Caspofungin; Cunninghamella; Diabetes Mellitus, Experimental; Echinocandins; Itraconazole; Lipopeptides; Male; Mice; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Thiazoles; Triazoles; Voriconazole

2010
A 67-Year-Old Male Patient With COVID-19 With Worsening Respiratory Function and Acute Kidney Failure.
    Chest, 2022, Volume: 161, Issue:1

    Topics: Acute Kidney Injury; Aged; Amphotericin B; Antibodies, Monoclonal, Humanized; Antifungal Agents; Atrial Fibrillation; Bronchoscopy; COVID-19; Dexamethasone; Diabetes Mellitus, Type 2; Fatal Outcome; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mucormycosis; Nitriles; Obesity; Oxygen Inhalation Therapy; Pulmonary Aspergillosis; Pyridines; Respiration, Artificial; SARS-CoV-2; Smoking; Tomography, X-Ray Computed; Triazoles; Voriconazole

2022
Invasive Pulmonary Aspergillosis Due to Aspergillus awamori: Role of Calcium Oxalate Crystal Precipitation Mimicking Mucormycosis.
    Mycopathologia, 2020, Volume: 185, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Biomarkers; Burkitt Lymphoma; Calcium Oxalate; Diagnosis, Differential; Genes, Fungal; Humans; Invasive Pulmonary Aspergillosis; Lung; Male; Middle Aged; Mucormycosis; Voriconazole

2020
Risk factors for mortality in patients with pulmonary mucormycosis.
    Mycoses, 2020, Volume: 63, Issue:7

    Topics: Aged; Antifungal Agents; Female; Hospital Mortality; Humans; Immunocompromised Host; Invasive Fungal Infections; Male; Middle Aged; Mucormycosis; Neutropenia; Pneumonia; Retrospective Studies; Risk Factors; Seoul; Tertiary Care Centers; Voriconazole

2020
The cost-effectiveness of isavuconazole compared to voriconazole, the standard of care in the treatment of patients with invasive mould diseases, prior to differential pathogen diagnosis in Spain.
    Mycoses, 2021, Volume: 64, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Clinical Laboratory Techniques; Cost-Benefit Analysis; Diagnosis, Differential; Fungi; Hospitalists; Humans; Mucormycosis; Nitriles; Pyridines; Spain; Standard of Care; Triazoles; Voriconazole

2021
Clinical utility of antifungal susceptibility testing in patients with fungal rhinosinusitis.
    Indian journal of medical microbiology, 2021, Volume: 39, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Azoles; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Mycoses; Sinusitis; Triazoles; Voriconazole

2021
New pharmacological opportunities for the treatment of invasive mould diseases.
    The Journal of antimicrobial chemotherapy, 2017, 03-01, Volume: 72, Issue:suppl_1

    Topics: Amphotericin B; Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Echinocandins; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Triazoles; Voriconazole

2017
Voriconazole associated mucormycosis in a patient with relapsed acute lymphoblastic leukemia and hematopoietic stem cell transplant failure: A case report.
    Journal de mycologie medicale, 2018, Volume: 28, Issue:3

    Topics: Adolescent; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Mucormycosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Treatment Failure; Voriconazole

2018
Molecular Confirmation of the Linkage between the
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:8

    Topics: Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Humans; Isoenzymes; Mucormycosis; Mutation; Open Reading Frames; Phylogeny; Rhizopus; Sterol 14-Demethylase; Voriconazole

2018
Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden.
    BMC infectious diseases, 2019, Feb-11, Volume: 19, Issue:1

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Case-Control Studies; Cost-Benefit Analysis; Decision Trees; Female; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Quality-Adjusted Life Years; Sweden; Triazoles; Voriconazole

2019
Invasive fungal consecutive infections in a patient with acute myeloid leukaemia.
    Nigerian journal of clinical practice, 2019, Volume: 22, Issue:4

    Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Female; Fever; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Mucormycosis; Neutropenia; Treatment Outcome; Voriconazole

2019
Rhizopus keratitis following corneal trauma.
    JAMA ophthalmology, 2013, Volume: 131, Issue:6

    Topics: Administration, Ophthalmic; Administration, Oral; Antifungal Agents; Bacteriological Techniques; Corneal Injuries; Corneal Ulcer; Diagnostic Techniques, Ophthalmological; Eye Infections, Fungal; Eye Injuries, Penetrating; Humans; Male; Middle Aged; Mucormycosis; Pyrimidines; Rhizopus; Treatment Outcome; Triazoles; Voriconazole

2013
Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphotericin c
    Mycoses, 2014, Volume: 57, Issue:11

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Echinocandins; Female; Fungi; History, 21st Century; Humans; Male; Middle Aged; Mucormycosis; United States; Voriconazole; Young Adult

2014
Keratitis caused by Absidia corymbifera in an immunocompetent male with no corneal injuries.
    Archivos de la Sociedad Espanola de Oftalmologia, 2015, Volume: 90, Issue:3

    Topics: Absidia; Administration, Ophthalmic; Adrenal Cortex Hormones; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Combined Modality Therapy; Corneal Transplantation; Corneal Ulcer; Drug Therapy, Combination; Humans; Immunocompetence; Male; Middle Aged; Mucormycosis; Ophthalmic Solutions; Staining and Labeling; Triazoles; Voriconazole

2015
Posaconazole liquid suspension in solid organ transplant recipients previously treated with voriconazole.
    Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:3

    Topics: Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Mucormycosis; Mycoses; Transplant Recipients; Transplants; Triazoles; Voriconazole

2015
Antifungal wound penetration of amphotericin and voriconazole in combat-related injuries: case report.
    BMC infectious diseases, 2015, Apr-15, Volume: 15

    Topics: Adult; Amphotericin B; Amputation, Surgical; Antifungal Agents; Aspergillosis; Blast Injuries; Burns; Critical Illness; Debridement; Drug Monitoring; Fusariosis; Humans; Male; Mucormycosis; Mycoses; Voriconazole; War-Related Injuries; Wounds, Penetrating

2015
Effect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12

    Topics: Agar; Animals; Antifungal Agents; Culture Media; Disease Models, Animal; Drosophila melanogaster; Female; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Rhizopus; Survival Analysis; Triazoles; Virulence; Voriconazole

2015
Comparison of the EUCAST and CLSI Broth Microdilution Methods for Testing Isavuconazole, Posaconazole, and Amphotericin B against Molecularly Identified Mucorales Species.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mucorales; Mucormycosis; Nitriles; Pyridines; Species Specificity; Triazoles; Voriconazole

2015
Prophylaxis with Isavuconazole or Posaconazole Protects Immunosuppressed Mice from Pulmonary Mucormycosis.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:5

    Topics: Animals; Antibiotic Prophylaxis; Antifungal Agents; Disease Models, Animal; Immunosuppression Therapy; Lung Diseases, Fungal; Mice; Mucormycosis; Nitriles; Pyridines; Rhizopus; Triazoles; Voriconazole

2017
Disseminated Rhizopus microsporus infection in a patient on oral corticosteroid treatment: a case report.
    The Netherlands journal of medicine, 2009, Volume: 67, Issue:1

    Topics: Adrenal Cortex Hormones; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antifungal Agents; Ciprofloxacin; Fatal Outcome; Humans; Itraconazole; Male; Mucormycosis; Prednisolone; Pyrimidines; Rhizopus; Triazoles; Voriconazole

2009
Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus.
    Medical mycology, 2008, Volume: 46, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Synergism; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Rhizopus; Triazoles; Voriconazole

2008
[Two cases of mycoses associated with hematologic disease].
    The Japanese journal of antibiotics, 2008, Volume: 61, Issue:5

    Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cunninghamella; Fatal Outcome; Humans; Liposomes; Male; Mucormycosis; Myelodysplastic Syndromes; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2008
Current controversies in treating invasive zygomycosis.
    Journal of pediatric hematology/oncology, 2010, Volume: 32, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Cunninghamella; Drug Therapy, Combination; Humans; Lung Diseases, Fungal; Mucormycosis; Pyrimidines; Triazoles; Voriconazole

2010
Fatal peritonitis caused by Rhizopus microsporus.
    Medical mycology, 2010, Volume: 48, Issue:8

    Topics: Antifungal Agents; Colon; Crohn Disease; Fatal Outcome; Female; Humans; Intestinal Perforation; Middle Aged; Mucormycosis; Peritonitis; Pyrimidines; Rhizopus; Triazoles; Voriconazole

2010
Increasing incidence of mucormycosis in University Hospital, Belgium.
    Emerging infectious diseases, 2010, Volume: 16, Issue:9

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Belgium; Child; Female; Hematologic Neoplasms; Hospitals, University; Humans; Incidence; Male; Middle Aged; Mucormycosis; Pyrimidines; Risk Factors; Triazoles; Voriconazole; Young Adult

2010
Disseminated Rhizomucor pusillus causing early multiorgan failure during hematopoietic stem cell transplantation for severe aplastic anemia.
    Journal of pediatric hematology/oncology, 2011, Volume: 33, Issue:3

    Topics: Amphotericin B; Anemia, Aplastic; Child; Female; Hematopoietic Stem Cell Transplantation; Humans; Mucormycosis; Multiple Organ Failure; Pyrimidines; Rhizomucor; Triazoles; Voriconazole

2011
Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies: analysis of eight patients.
    International journal of hematology, 2011, Volume: 93, Issue:3

    Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Biopsy; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Retrospective Studies; Survival Rate; Triazoles; Voriconazole

2011
Failure of haematopoietic recovery overcome by SCT despite invasive mucormycosis infection.
    Bone marrow transplantation, 2012, Volume: 47, Issue:4

    Topics: Adult; Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Mucormycosis; Pyrimidines; Radiography; Remission Induction; Transplantation, Homologous; Triazoles; Voriconazole

2012
Rhinocerebral mucormycosis: a diagnostic challenge and therapeutic dilemma in immunocompetent host.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2012, Volume: 70, Issue:6

    Topics: Adult; Amphotericin B; Antifungal Agents; Central Nervous System Fungal Infections; Eye Infections, Fungal; Female; Humans; Hyphae; Immunocompetence; Male; Maxilla; Middle Aged; Mucormycosis; Nose Diseases; Orbit; Paranasal Sinus Diseases; Pyrimidines; Triazoles; Voriconazole

2012
[Mucormycosis: retrospective evaluation of 12 cases].
    Mikrobiyoloji bulteni, 2011, Volume: 45, Issue:3

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Brain Diseases; Diabetes Complications; Female; Hematologic Diseases; Humans; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Nose Diseases; Orbital Diseases; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2011
How does antifungal pharmacology differ for mucormycosis versus aspergillosis?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 54 Suppl 1

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Cell Membrane; Cell Wall; Drug Resistance, Multiple, Fungal; Ergosterol; Gene Duplication; Genome, Fungal; Genomic Instability; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Rhizopus; Species Specificity; Triazoles; Virulence Factors; Voriconazole

2012
Future directions in mucormycosis research.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 54 Suppl 1

    Topics: Antifungal Agents; Aspergillus; Biomedical Research; Early Diagnosis; Genome, Fungal; Humans; Immunocompromised Host; Mucormycosis; Pyrimidines; Rhizopus; Risk Factors; Triazoles; Voriconazole

2012
The surgical management of rhinocerebral mucormycosis.
    Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2013, Volume: 41, Issue:4

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brain Diseases; Cause of Death; Combined Modality Therapy; Diagnosis, Differential; Fatal Outcome; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Maxillary Sinusitis; Middle Aged; Mucormycosis; Nose Diseases; Paranasal Sinus Diseases; Pyrimidines; Triazoles; Voriconazole; Young Adult

2013
Concurrent pulmonary Aspergillus fumigatus and mucor infection in a cardiac transplant recipient: a case report.
    Transplantation proceedings, 2013, Volume: 45, Issue:2

    Topics: Air Microbiology; Antifungal Agents; Cardiomyopathy, Dilated; Cyclonic Storms; Environmental Exposure; Heart Transplantation; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Mucormycosis; Pyrimidines; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2013
Reflections on the approach to treatment of a mycologic disaster.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Cladosporium; Humans; Mucormycosis; Mycoses; Pyrimidines; Rhizopus; Rhodotorula; Triazoles; Voriconazole

2013
Disseminated mucormycosis associated with invasive pulmonary aspergillosis in a patient treated for post-transplant high-grade non-Hodgkin's lymphoma.
    Leukemia & lymphoma, 2004, Volume: 45, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis, Allergic Bronchopulmonary; Caspofungin; Echinocandins; Fatal Outcome; Female; Humans; Kidney Transplantation; Lipopeptides; Lymphoma, Non-Hodgkin; Middle Aged; Mucormycosis; Peptides, Cyclic; Pyrimidines; Treatment Failure; Triazoles; Voriconazole

2004
Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Feb-15, Volume: 40, Issue:4

    Topics: Absidia; Adult; Antifungal Agents; Child, Preschool; Female; Hematologic Diseases; Humans; Immunocompromised Host; Male; Middle Aged; Mucormycosis; Pyrimidines; Rhizomucor; Rhizopus; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2005
Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Mar-01, Volume: 40, Issue:5

    Topics: Aged; Antifungal Agents; Fever; Humans; Mucormycosis; Neutropenia; Pyrimidines; Treatment Failure; Triazoles; Voriconazole

2005
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
    Haematologica, 2005, Volume: 90 Suppl

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Communicable Diseases, Emerging; Dermatomycoses; Disease Susceptibility; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Sinusitis; Transplantation Conditioning; Triazoles; Viscera; Voriconazole

2005
Early fatal Rhizopus infection on voriconazole prophylaxis following allogeneic stem cell transplantation.
    Bone marrow transplantation, 2007, Volume: 39, Issue:12

    Topics: Antifungal Agents; Drug Resistance, Fungal; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mucormycosis; Pyrimidines; Rhizopus; Transplantation, Homologous; Triazoles; Voriconazole

2007
Successful treatment and limb salvage of mucor necrotizing fasciitis after kidney transplantation with posaconazole.
    Hawaii medical journal, 2007, Volume: 66, Issue:3

    Topics: Alcaligenes; Amphotericin B; Amputation, Surgical; Antifungal Agents; Cefazolin; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Drug Resistance, Multiple, Fungal; Escherichia coli Infections; Fatal Outcome; Fluconazole; Gangrene; Graft Rejection; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg; Leg Ulcer; Male; Middle Aged; Mucor; Mucormycosis; Penicillanic Acid; Phosphatidylcholines; Phosphatidylglycerols; Piperacillin; Postoperative Complications; Pyrimidines; Renal Dialysis; Reoperation; Sepsis; Skin Transplantation; Tazobactam; Triazoles; Voriconazole

2007
Inherited long QT syndrome revealed by antifungals drug-drug interaction.
    Journal of clinical pharmacy and therapeutics, 2007, Volume: 32, Issue:3

    Topics: Acute Disease; Adolescent; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Female; Genotype; Humans; Injections, Intravenous; Leukemia, Myeloid; Long QT Syndrome; Mixed Function Oxygenases; Mucormycosis; Pyrimidines; Torsades de Pointes; Triazoles; Voriconazole

2007
[Breakthrough pulmonary mucormycosis during voriconazole treatment after reduced-intensity cord blood transplantation for a patient with acute myeloid leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2007, Volume: 48, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cord Blood Stem Cell Transplantation; Echinocandins; Fatal Outcome; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Mucormycosis; Peptides, Cyclic; Pyrimidines; Transplantation Conditioning; Triazoles; Voriconazole

2007
Pulmonary mucormycosis in a nondiabetic renal allograft recipient successfully managed by medical therapy alone.
    Transplantation, 2007, Jun-27, Volume: 83, Issue:12

    Topics: Antifungal Agents; Humans; Kidney Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Mucorales; Mucormycosis; Postoperative Complications; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
Simultaneous mold infections in an orthotopic heart transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2008, Volume: 10, Issue:5

    Topics: Amphotericin B; Antibodies, Monoclonal; Antifungal Agents; Aspergillus fumigatus; Basiliximab; Cardiomyopathy, Dilated; Debridement; Dermatomycoses; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Mucormycosis; Prosthesis-Related Infections; Pulmonary Aspergillosis; Pyrimidines; Recombinant Fusion Proteins; Rhizopus; Triazoles; Voriconazole

2008
Absidia corymbifera necrotizing cellulitis in an immunocompromised patient while on voriconazole treatment.
    Annals of hematology, 2008, Volume: 87, Issue:8

    Topics: Absidia; Aged; Antifungal Agents; Diabetes Complications; Foot Injuries; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Mucormycosis; Pyrimidines; Triazoles; Voriconazole

2008